2024 FACA panel voting results: Clinical Laboratory Fee Schedule		
"0445U: B-amyloid (abeta42) and phospho tau (181p) (ptau181), electrochemiluminescent immunoassay (eclia), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0358U	9
	Gapfill	0
	Abstain	0
		
82XX0: Beta-amyloid; 1-40 (Abeta 40)	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0358U x 0.5	8
	Gapfill	0
	Abstain	1
		
82XX1: Beta-amyloid; 1-42 (Abeta 42)	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk 0358U x 0.5	8
	Gapfill	0
	Abstain	1
		
83XX0: Neurofilament light chain (NfL)	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0358U x 0.5	9
	Gapfill	0
	Abstain	0
		
"86XX1: Streptococcus pneumoniae antibody (IgG), serotypes, multiplex immunoassay, quantitative"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk 87633	1
	Gapfill	7
	Abstain	1
		
"8X3XX: Tau, total (tTau)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0358U x 0.5	8
	Gapfill	0
	Abstain	1
		
"XX42U (0426U): Melatonin levels test, sleep study, 7 or 9 sample melatonin profile (cortisol optional), enzyme-linked immunosorbent assay (ELISA), saliva, screening/preliminary"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 80307	8
	Gapfill	1
	Abstain	0
		
"XX65U: Infectious disease (bacteria, viruses, fungi, and parasites), cerebrospinal fluid (CSF), metagenomic next-generation sequencing (DNA and RNA), bioinformatic analysis, with positive pathogen identification"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0323U	8
	Gapfill	0
	Abstain	1
		
86041: Acetycholine receptor (AchR); binding antibody	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 86341	8
	Gapfill	0
	Abstain	1
		
86042: Acetylcholine receptor (AChR); blocking antibody	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 86341	9
	Gapfill	0
	Abstain	0
		
86043: Acetylcholine receptor (AChR); modulating antibody	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 86053	8
	Gapfill	0
	Abstain	1
		
86366: Muscle-specific kinase (MuSK) antibody	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 84586	8
	Gapfill	0
	Abstain	1
		
"0431U: Glycine receptor alpha1 IgG, serum or cerebrospinal fluid (CSF), live cell-binding assay (LCBA), qualitative"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 84238	8
	Gapfill	0
	Abstain	1
		
"0432U: Kelch-like protein 11 (KLHL11) antibody, serum or cerebrospinal fluid (CSF), cell-binding assay, qualitative"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 84238	7
	Crosswalk: 0345U+ 0419U+ 0411U	0
	Gapfill	1
	Abstain	1
		
"0443U: Neurofilament light chain (nfl), ultra-sensitive immunoassay, serum or cerebrospinal fluid"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0358U x 0.5	9
	Gapfill	0
	Abstain	0
		
"XX32U (0451U): Oncology (multiple myeloma), LCMS/MS, peptide ion quantification, serum, results compared with baseline to determine monoclonal paraprotein abundance"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0077U	8
	Gapfill	1
	Abstain	0
		
"0394U: Perfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic
acid), 16 PFAS compounds by liquid chromatography with tandem mass spectrometry (LCMS/MS), plasma or serum, quantitative"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0263U	0
	Gapfill	9
	Abstain	0
		
"8X051: Infectious agent detection by nucleic acid (DNA or RNA); Mycobacterium tuberculosis, rifampin resistance, amplified probe technique"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 87556+ 87641	8
	Crosswalk: 1/6th of  0008U	0
	Gapfill	0
	Abstain	1
		
"8X3X0: Tau, phosphorylated (eg, pTau 181, pTau 217), each"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0358U x 0.5	8
	Gapfill	0
	Abstain	1
		
"8XX00: Infectious disease, bacterial vaginosis and vaginitis, real-time PCR amplification of DNA markers for Atopobium vaginae, Atopobium species, and Megasphaera type 1, Bacterial VaginosisAssociated Bacteria 2 (BVAB-2)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81514	8
	Gapfill	0
	Abstain	1
		
"0435U Oncology, chemotherapeutic drug cytotoxicity assay of cancer stem cells (CSCs), from cultured CSCs and primary tumor cells, categorical drug response reported based on cytotoxicity percentage observed, minimum of 14 drugs or drug combinations"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0248U	9
	Gapfill	0
	Abstain	0
		
"XX84U: Human papillomavirus (HPV), E6/E7 markers for high-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68), cervical cells, branched-chain capture hybridization, reported as negative or positive for high risk for HPV"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 87624	9
	Gapfill	0
	Abstain	0
		
"XX89U: Infectious disease (vaginal infection), identification of 32 pathogenic organisms, swab, real-time PCR, reported as positive or negative for each organism"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 87507+87506	9
	Gapfill	0
	Abstain	0
		
"XX99U: Gastroenterology (irritable bowel disease [IBD]), immunoassay for the quantitative determination of infliximab (IXL)..."	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 80230	9
	Gapfill	0
	Abstain	0
		
"XX97U: Oncology (solid tumor), tumor cell culture in 3D microenvironment, 36 or more drug panel, reported as tumor-response prediction for each drug"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0248U	8
	Crosswalk: 0248U x 3	1
	Gapfill	0
	Abstain	0
		
"XX98U: Gastroenterology (irritable bowel disease [IBD]), immunoassay for the quantitative determination of adalimumab (ADL)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 80145	9
	Gapfill	0
	Abstain	0
		
"0430U: Gastroenterology, malabsorption evaluation of alpha-1-antitrypsin, calprotectin, pancreatic elastase and reducing substances, feces, quantitative"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 82103+83993+82653+84376	8
	Gapfill	0
	Abstain	1
		
"0427U: Monocyte distribution width, whole blood (List separately in addition to code for primary procedure)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 85049	1
	Gapfill	7
	Abstain	1
		
"X102U: Therapeutic drug monitoring, 200 or more drugs or substances, LC-MS/MS, plasma, qualitative and quantitative"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: G0483	6
	Crosswalk: 0063U	0
	Gapfill	3
	Abstain	0
		
"XX85U: Neurology (Alzheimer disease), beta amyloid (A?40, A?42, A?42/40 ratio) and tau-protein (p-tau217, np-tau217, p-tau217/np-tau217 ratio), blood"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0384U	8
	Crosswalk: 0247U	0
	Gapfill	0
	Abstain	1
		
"XX88U: Infectious disease (urinary tract infection), identification of 17 pathologic organisms, urine, real-time PCR, reported as positive or negative for each organism"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 87507	9
	Gapfill	0
	Abstain	0
		
"87XX0: Infectious agent detection by nucleic acid (DNA or RNA); Pneumocystis jirovecii, amplified probe technique"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 87481	8
	Crosswalk: 1/6th of code 0008U	0
	Gapfill	0
	Abstain	1
		
"87XX1: Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), separately reported high-risk types (eg, 16, 18, 31,45, 51, 52) and high-risk pooled result(s)"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Abstain	0
	Gapfill	0
	Crosswalk: 87624 +87625 x 2	4
	Crosswalk: 87624 + 87625	4
		
"XX48U (0468U): Hepatology (nonalcoholic steatohepatitis [NASH]), miR-34a5p, alpha 2-macroglobulin, YKL40, HbA1c"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0003M x 0.5	9
	Gapfill	0
	Abstain	0
		
"0436U: Oncology (lung), plasma analysis of 388 proteins, using aptamerbased proteomics technology, predictive algorithm reported"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 0249U	1
	Gapfill	7
	Abstain	0
		
"0446U: Autoimmune diseases (systemic lupus erythematosus [sle]), analysis of 10 cytokine soluble mediator biomarkers by immunoassay"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81490	8
	Gapfill	0
	Abstain	1
		
"0447U: Autoimmune diseases (systemic lupus erythematosus [sle]), analysis of 11 cytokine soluble mediator biomarkers by immunoassay"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81490	8
	Gapfill	0
	Abstain	1
		
"X103U: Therapeutic drug monitoring, 90 or more pain and mental health drugs or substances, LC-MS/MS, plasma, qualitative and quantitative therapeutic minimally effective range of prescribed and non-prescribed medications"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: G0483	6
	Crosswalk: 0063U	0
	Gapfill	3
	Abstain	0
		
"0429U: Human papillomavirus (HPV), oropharyngeal swab, 14 high-risk types (ie, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 87624+87625	9
	Crosswalk: 87636	0
	Gapfill	0
	Abstain	0
		
"XX39U (0458U): Oncology (breast cancer), S100A8 and S100A9, by enzymelinked immunosorbent assay (ELISA), tear fluid with age, algorithm reported as a risk score"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81500	9
	Gapfill	0
	Abstain	0
		
"X101U: Therapeutic drug monitoring, 80 or more psychoactive drugs or substances, LC-MS/MS, plasma, qualitative and quantitative therapeutic"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: G0483	6
	Crosswalk: 0063U	0
	Gapfill	3
	Abstain	0
		
"XX63U: Obstetrics (preeclampsia), biochemical assay of soluble fms-like tyrosine kinase 1 (sFlT-1) and placental growth factor (PIGF), serum, ratio"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0243U x 2	8
	Gapfill	0
	Abstain	1
		
"87593: Infectious agent detection by nucleic acid (DNA or RNA); Orthopoxvirus (eg,
monkeypox virus, cowpox virus, vaccinia virus), amplified probe technique, each"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 87635	9
	Gapfill	0
	Abstain	0
		
"0442U: Infectious disease (respiratory infection), myxovirus resistance protein a (mxa) and c-reactive protein (crp), fingerstick whole blood specimen, each biomarker reported as present or absent"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 87811	9
	Gapfill	0
	Abstain	0
		
"XX38U (0457U): Perfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic acid), 9 PFAS compounds by LC-MS/MS, plasma or serum, quantitative"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0394U	8
	Gapfill	1
	Abstain	0
		
"X104U: Therapeutic drug monitoring, medications specific to pain, depression, and anxiety, LC-MS/MS, plasma"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: G0483	6
	Crosswalk: 0063U	0
	Gapfill	3
	Abstain	0
		
"XX31U (0450U): Oncology (multiple myeloma), liquid chromatography with tandem mass spectrometry (LCMS/MS)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0077U	9
	Gapfill	0
	Abstain	0
		
"XX36U (0455U): Infectious agents (sexually transmitted infection), Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0402U	9
	Gapfill	0
	Abstain	0
		
"XX66U: Infectious disease (Neisseria gonorrhoeae), sensitivity, ciprofloxacin resistance (gyrA S91F point mutation), oral, rectal, or vaginal swab, algorithm reported as probability of fluoroquinolone resistance"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk to 87563	0
	Crosswalk to 87641	0
	Gapfill	9
	Abstain	0
		
"XX43U (0463U): Oncology (cervix), mRNA gene expression profiling of 14 biomarkers (E6 and E7 of the highest-risk human papillomavirus [HPV] types 16, 18, 31, 33, 45, 52, 58), by real-time nucleic acid sequence-based amplification"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0403U	2
	Gapfill	7
	Abstain	0
		
"8X050: Infectious agent detection by nucleic acid (DNA or RNA); Helicobacter pylori (H. pylori), clarithromycin resistance, amplified probe technique"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 87150	7
	Crosswalk: 87541 plus 87641	0
	Crosswalk: 87640 plus  87641	1
	Crosswalk: 1/6 of 0008U	0
	Gapfill	0
	Abstain	1
		
"XX52U (472U): Carbonic anhydrase VI (CA VI), parotid specific/secretory protein (PSP) and salivary protein (SP1) IgG, IgM, and IgA antibodies"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Gapfill	9
	Abstain	0
		
"XX62U: Tau, phosphorylated, pTau217"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 0358U	0
	Crosswalk: 0358U x 0.5	7
	Gapfill	0
	Abstain	1
		
"XX72U: Infectious disease (Mycoplasma genitalium), macrolide sensitivity (23S rRNA point mutation), oral, rectal, or vaginal swab, algorithm reported as probability of macrolide resistance"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 87641	2
	Gapfill	7
	Abstain	0
		
"0441U: Infectious disease (bacterial, fungal, or viral infection), semiquantitative biomechanical assessment (via deformability cytometry), whole blood, with algorithmic analysis and result reported as an index"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0305U x 0.5	1
	Gapfill	8
	Abstain	0
		
"XX40U (0459U): ?-amyloid (Abeta42) and total tau (tTau), electrochemiluminescent immunoassay (ECLIA), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0358U	9
	Gapfill	0
	Abstain	0
		
"0420U: Oncology (urothelial), mRNA expression profiling by real-time quantitative PCR of MDK, HOXA13, CDC2, IGFBP5, and CXCR2"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 0012M	2
	Crosswalk: 0012M+ 0356U	0
	Gapfill	6
	Abstain	0
		
"XX95U: Oncology (prostate), augmentative algorithmic analysis of digitized whole-slide imaging of histologic features for microsatellite instability"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0220U	8
	Gapfill	1
	Abstain	0
		
"XX96U: Oncology (prostate), augmentative algorithmic analysis of digitized whole-slide imaging of histologic features for microsatellite instability"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0220U	9
	Gapfill	0
	Abstain	0
		
"0439U: Cardiology (coronary heart disease [chd]), dna, analysis of 5 single-nucleotide polymorphisms (snps) (rs11716050 [loc105376934], rs6560711 [wdr37], rs3735222 [scin/loc107986769]"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81493	9
	Gapfill	0
	Abstain	0
		
"0440U: Cardiology (coronary heart disease [chd]), dna, analysis of 10 single-nucleotide polymorphisms (snps) (rs710987 [linc010019], rs1333048"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81493	8
	Gapfill	1
	Abstain	0
		
"XX46U (0466U): Cardiology (coronary artery disease [CAD]), DNA, genomewide association studies (564856 single-nucleotide polymorphisms [SNPs]"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0078U	0
	Gapfill	9
	Abstain	0
		
"XX73U: Oncology (cutaneous or uveal melanoma), circulating tumor cell selection, morphological characterization and enumeration based"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0337U	9
	Gapfill	0
	Abstain	0
		
"XX75U: Oncology (solid tumor), circulating tumor cell selection, morphological characterization and enumeration based on differential "	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0338U	9
	Gapfill	0
	Abstain	0
		
"XX74U: Oncology (solid tumor), circulating tumor cell selection, morphological characterization and enumeration based on differential epithelial cell "	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0338U	9
	Gapfill	0
	Abstain	0
		
"0355U: APOL1 (apolipoprotein L1) (eg, chronic kidney disease), risk variants (G1, G2)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Gapfill	9
	Abstain	0
		
"XX83U: Autoinflammatory disease (VEXAS syndrome), DNA, UBA1 gene mutations, targeted variant analysis (M41T, M41V, M41L, c.118-2A>C, c.118-1G>C, c.118-9_118-2del, S56F, S621C)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81233	9
	Gapfill	0
	Abstain	0
		
"0437U: Psychiatry (anxiety disorders), mRNA, gene expression profiling by RNA sequencing of 15 biomarkers, whole blood, algorithm reported as predictive risk score"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0293U	9
	Gapfill	0
	Abstain	0
		
"XX37U (0456U): Autoimmune (rheumatoid arthritis), next-generation sequencing (NGS), gene expression testing of 19 genes, whole blood, with analysis of anticyclic citrullinated peptides (CCP) levels, combined with sex"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0203U	9
	Gapfill	0
	Abstain	0
		
"0428U: Oncology (breast), targeted hybrid-capture genomic sequence analysis panel, circulating tumor DNA (ctDNA) analysis of 56 or more genes"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81464	9
	Gapfill	0
	Abstain	0
		
"XX34U (0453U): Oncology (colorectal cancer), cellfree DNA (cfDNA), methylationbased quantitative PCR assay"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81327	9
	Gapfill	0
	Abstain	0
		
"XX87U: Oncology (colorectal), cell-free DNA, 8 genes for mutations, 7 genes for methylation by real-time RT-PCR, and 4 proteins"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Gapfill	9
	Abstain	0
		
"XX80U: Oncology (colorectal), blood, quantitative measurement of cell-free DNA (cfDNA)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Gapfill	9
	Abstain	0
		
"XX70U: Obstetrics (fetal antigen noninvasive prenatal test), cell-free DNA sequence analysis for the detection of the fetal presence or absence of 1 or more"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81422	7
	Gapfill	0
	Abstain	2
		
"XX76U: Obstetrics (single-gene noninvasive prenatal test), cell-free DNA sequence analysis of 1 or more targets"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Gapfill	7
	Abstain	2
		
"XX82U: Red blood cell antigen (fetal RhD gene analysis), next-generation sequencing of circulating cell-free DNA (cfDNA)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81422	8
	Gapfill	0
	Abstain	1
		
"XX50U (0470U): Oncology (oropharyngeal), detection of minimal residual disease by next-generation sequencing (NGS) "	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0356U +87625	2
	Gapfill	7
	Abstain	0
		
"81462: Solid organ neoplasm, genomic sequence analysis panel, cell-free nucleic acid (eg, plasma), interrogation for sequence variants"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81445 x 2	9
	Gapfill	0
	Abstain	0
		
"81464: Solid organ neoplasm, genomic sequence analysis panel, cell-free nucleic acid (eg, plasma), interrogation for sequence variants"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Gapfill	9
	Abstain	0
		
"0422U: Oncology (pan-solid tumor), analysis of DNA biomarker response to anti-cancer therapy using cell-free circulating DNA, biomarker comparison to a previous..."	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Gapfill	9
	Abstain	0
		
"XX41U (0460U): Oncology, whole blood or buccal, DNA single-nucleotide polymorphism (SNP) genotyping by real-time PCR of 24 genes, with variant analysis and reported phenotypes"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0055U	6
	Gapfill	3
	Abstain	0
		
"XX69U: Oncology (solid tumor), cell-free DNA and RNA by next-generation sequencing, interpretative report for germline mutations, clonal hematopoiesis of indeterminate potential, and tumor-derived single-nucleotide variants"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0211U	9
	Gapfill	0
	Abstain	0
		
"XX77U: Oncology (pan-solid tumor), next-generation sequencing analysis of tumor methylation markers present in cell-free circulating tumor DNA"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0405U x 2.0	8
	Gapfill	0
	Abstain	1
		
"8156X: Transplantation medicine (allograft rejection, kidney), mRNA, gene expression profiling by quantitative polymerase chain reaction (qPCR) of 139 genes"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81595	9
	Gapfill	0
	Abstain	0
		
"XX78U: Transplantation medicine, quantification of donor-derived cell-free DNA using next-generation sequencing, plasma, reported as percentage of donor-derived cell-free DNA (cfDNA)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0331U	8
	Crosswalk: 0118U	1
	Gapfill	0
	Abstain	0
		
"XX93U: Transplantation medicine, quantification of donor-derived cell-free DNA using 40 single-nucleotide polymorphism (SNPs)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Gapfill	9
	Abstain	0
		
"XX94U: Transplantation medicine, quantification of donor-derived cell-free DNA using up to 12 single-nucleotide polymorphism (SNPs) previously identified"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Gapfill	9
	Abstain	0
		
"0425U: Genome (eg, unexplained constitutional or heritable disorder or syndrome), rapid sequence analysis, each comparator genome (eg, parents, siblings)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81426 x 1.51	2
	Gapfill	7
	Abstain	0
		
"0426U: Genome (eg, unexplained constitutional or heritable disorder or syndrome), ultra-rapid sequence analysis"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Gapfill	9
	Abstain	0
		
"0449U: Carrier screening for severe inherited conditions (eg, cystic fibrosis, spinal muscular atrophy, beta hemoglobinopathies"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 81222+81329+81269+81363+81223+81259+81364	4
	Crosswalk: 81412	2
	Crosswalk: 81162	0
	Gapfill	1
	Abstain	1
		
"XX49U (0469U): Rare diseases (constitutional/heritable disorders), whole genome sequence analysis for chromosomal abnormalities, copy number variants"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81349+81265+88235	9
	Gapfill	0
	Abstain	0
		
"0417U: Rare diseases (constitutional/heritable disorders), whole mitochondrial genome sequence with heteroplasmy detection and deletion analysis"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81460+81465+81440	9
	Gapfill	0
	Abstain	0
		
"0X00M (0020M): Oncology (central nervous system), analysis of 30000 DNA methylation loci by methylation array, utilizing DNA extracted from"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	0016M	9
	Gapfill	0
	Abstain	0
		
"XX67U: Isocitrate dehydrogenase 1 (IDH1), isocitrate dehydrogenase 2 (IDH2), and telomerase reverse transcriptase (TERT) promoter (eg, central nervous system [CNS] tumors)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81120+81121+81345	8
	Crosswalk: 81120	0
	Gapfill	0
	Abstain	1
		
"0421U: Oncology (colorectal) screening, quantitative real-time target and signal amplification of 8 RNA markers (GAPDH, SMAD4, ACY1, AREG, CDH1, KRAS, TNFRSF10B,  GLN2)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81528	9
	Gapfill	0
	Abstain	0
		
"XX44U (0464U): Oncology (colorectal) screening, quantitative real-time target and signal amplification, methylated DNA markers, including LASS4, LRRC4 and PPP2R5C"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81528	5
	Crosswalk: 81528 x 1.25	4
	Gapfill	0
	Abstain	0
		
"XX51U (0471U): Oncology (colorectal cancer), qualitative real-time PCR of 35 variants of KRAS and NRAS genes (exons 2, 3, 4), formalinfixed paraffin-embedded (FFPE), predictive, identification of detected mutations"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81275+81276+81311	9
	Gapfill	0
	Abstain	0
		
"XX68U: Oncology (colorectal), next-generation sequencing for mutation detection in 43 genes and methylation pattern in 45 genes, blood"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Gapfill	9
	Abstain	0
		
"XX86U: Oncology (colorectal and lung), DNA from formalin-fixed paraffin-embedded (FFPE) tissue, next-generation sequencing of 8 genes"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81445	9
	Gapfill	0
	Abstain	0
		
"XX90U: Gastroenterology (Barrett's esophagus), esophageal cells, DNA methylation analysis by next-generation sequencing of at least"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0114U	9
	Gapfill	0
	Abstain	0
		
"XX54U (0475U): Hereditary prostate cancerrelated disorders, genomic sequence analysis panel using next-generation sequencing (NGS), Sanger sequencing, multiplex ligation-dependent probe amplification (MLPA)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81435 + (81436 x 0.25)	8
	Crosswalk: 0101U	0
	Crosswalk: 0103U	1
	Gapfill	0
	Abstain	0
		
"XX55U (0474U): Hereditary pan-cancer (eg, hereditary sarcomas, hereditary endocrine tumors, hereditary neuroendocrine tumors, hereditary cutaneous melanoma), genomic sequence analysis "	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk to 0103U	2
	Crosswalk to 0101U	0
	Crosswalk: 81435 + (81436 x 0.25)	7
	Gapfill	0
	Abstain	0
		
"81432: Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81432+ (81433 x 0.25)	6
	Crosswalk: 81432 + 81433	2
	Gapfill	1
	Abstain	0
		
"81435: Hereditary colon cancer-related disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81435+(81436 x 0.25)	7
	Crosswalk: 81435 + 81436	2
	Gapfill	0
	Abstain	0
		
"81437: Hereditary neuroendocrine tumor-related disorders (eg, medullary thyroid carcinoma, parathyroid carcinoma, malignant pheochromocytoma or paraganglioma)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81437+(81438 x 0.25)	7
	Crosswalk: 81437+81438	2
	Gapfill	0
	Abstain	0
		
"0448U: Oncology (lung and colon cancer), dna, qualitative, nextgeneration sequencing detection of single-nucleotide variants and deletions in egfr and kras genes"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0111U	1
	Crosswalk: 81235 + 81275	8
	Gapfill	0
	Abstain	0
		
"XX61U: Oncology (non-small cell lung cancer), DNA and RNA, digital PCR analysis of 9 genes (EGFR, KRAS, BRAF, ALK, ROS1, RET, NTRK 1/2/3, ERBB2, and MET)"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Gapfill	9
	Abstain	0
		
"XX91U: Oncology (ovarian), DNA, whole-genome sequencing with 5-hydroxymethylcytosine (5hmC) enrichment, using whole blood or plasma, algorithm reported as cancer detected or not detected"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 0410U	8
	Gapfill	0
	Abstain	0
		
"XX92U: Oncology (pancreatic cancer), augmentative algorithmic analysis of 16 genes from previously sequenced RNA whole-transcriptome data, reported as probability of predicted molecular subtype"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Gapfill	9
	Abstain	0
		
"81457: Solid organ neoplasm, genomic sequence analysis panel, interrogation for sequence variants; DNA analysis, microsatellite instability"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81445 x 1.5	9
	Gapfill	0
	Abstain	0
		
"81458: Solid organ neoplasm, genomic sequence analysis panel, interrogation for sequence variants; DNA analysis, copy number variants and microsatellite instability"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81445 x 2	9
	Gapfill	0
	Abstain	0
		
"81459: Solid organ neoplasm, genomic sequence analysis panel, interrogation for sequence variants; DNA analysis or combined DNA and RNA analysis, copy number variants, microsatellite instability, tumor mutation burden, and rearrangements"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 81445	0
	Crosswalk: 81445 x 2.5	5
	Gapfill	3
	Abstain	0
		
"0444U: Oncology (solid organ neoplasia), targeted genomic sequence analysis panel of 361 genes, interrogation for gene fusions, translocations"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81455	9
	Gapfill	0
	Abstain	0
		
"XX53U (0473U): Oncology (solid tumor), nextgeneration sequencing (NGS) of DNA from formalin-fixed paraffinembedded (FFPE) tissue with comparative sequence analysis from a matched normal specimen (blood or saliva)"	Activity type	Multiple choice
	Total responses	0
	Unique participants	0
	Response options	Count
	Crosswalk: 0037U	0
	Gapfill	0
	Abstain	0
		
"XX71U: Oncology (solid tumor), cell-free circulating DNA, targeted genomic sequence analysis panel of 84 genes, interrogation for sequence variants"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 0326U	6
	Gapfill	0
	Abstain	2
		
"0424U: Oncology (prostate), exosomebased analysis of 53 small noncoding RNAs (sncRNAs) by quantitative reverse transcription polymerase chain reaction"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0343U	9
	Gapfill	0
	Abstain	0
		
"0433U: Oncology (prostate), 5 DNA regulatory markers by quantitative PCR, whole blood, algorithm, including prostate-specific antigen, reported as likelihood of cancer"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 0012M	9
	Gapfill	0
	Abstain	0
		
"XX33U (0452U): Oncology (bladder), methylated PENK DNA detection by linear target enrichment-quantitative methylation-specific real-time PCR (LTE-qMSP), urine, reported as likelihood of bladder cancer"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81327	9
	Gapfill	0
	Abstain	0
		
"XX45U (0465U): Oncology (urothelial carcinoma), DNA, quantitative methylationspecific PCR of 2 genes (ONECUT2, VIM), algorithmic analysis reported as positive or negative"	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81551	9
	Crosswalk: 0012M	0
	Gapfill	0
	Abstain	0
		
"XX47U (0467U): Oncology (bladder), DNA, nextgeneration sequencing (NGS) of 60 genes and whole genome aneuploidy, urine, algorithms..."	Activity type	Multiple choice
	Total responses	9
	Unique participants	9
	Response options	Count
	Crosswalk: 81455	5
	Gapfill	4
	Abstain	0
		
"XX79U: Oncology (prostate), analysis of circulating plasma proteins (tPSA, fPSA, KLK2, PSP94, and GDF15), germline polygenic risk score (60 variants)"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 81539	8
	Crosswalk: 0359U	0
	Gapfill	0
	Abstain	0
		
"XX81U: Oncology (prostate), mRNA gene-expression profiling by real-time RT-PCR of 6 genes (FOXM1, MCM3, MTUS1, TTC21B, ALAS1, and PPP2CA)"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 0047U	8
	Gapfill	0
	Abstain	0
		
"88XX0: Cytogenomic genome-wide analysis, hematologic malignancy, structural variations and copy number variations, optical genome mapping (OGM)"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 0331U	8
	Gapfill	0
	Abstain	0
		
"0413U: Oncology (hematolymphoid neoplasm), optical genome mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 0331U	8
	Gapfill	0
	Abstain	0
		
"XX35U (0454U): Rare diseases (constitutional/heritable disorders), identification of copy number variations, inversions, insertions"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 0260U	8
	Gapfill	0
	Abstain	0
		
"0423U: Psychiatry (eg, depression, anxiety), genomic analysis panel, including variant analysis of 26 genes, buccal swab, report including metabolizer status and risk of drug toxicity by condition"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 0349U	8
	Crosswalk: 0345U + 0419U+ 0411U	0
	Gapfill	0
	Abstain	0
		
"0434U: Drug metabolism (adverse drug reactions and drug response), genomic analysis panel, variant analysis of 25 genes with reported phenotypes"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 0348U	7
	Gapfill	1
	Abstain	0
		
"0438U: Drug metabolism (adverse drug reactions and drug response), buccal specimen, gene-drug interactions, variant analysis of 33 genes"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 0350U	8
	Gapfill	0
	Abstain	0
		
"XX30U (0461U): Oncology, pharmacogenomic analysis of single-nucleotide polymorphism (SNP) genotyping by real-time PCR of 24 genes"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 0055U	3
	Gapfill	5
	Abstain	0
		
"XX64U: Drug metabolism, psychiatry (eg, major depressive disorder, general anxiety disorder, attention deficit hyperactivity disorder [ADHD], schizophrenia)"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 81418	8
	Gapfill	0
	Abstain	0
		
"XX60U: Drug metabolism, psychiatry (eg, major depressive disorder, general anxiety disorder, attention deficit hyperactivity disorder [ADHD], schizophrenia)"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 81418	8
	Gapfill	0
	Abstain	0
		
"X100U: Drug metabolism, whole blood, pharmacogenomic genotyping of 40 genes and CYP2D6 copy number variant analysis, reported as metabolizer status"	Activity type	Multiple choice
	Total responses	8
	Unique participants	8
	Response options	Count
	Crosswalk: 0349U	8
	Gapfill	0
	Abstain	0
